Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorKUHN, Johann
dc.contributor.authorOLIE, Valerie
dc.contributor.authorGRAVE, Clemence
dc.contributor.authorLE STRAT, Yann
dc.contributor.authorBONALDI, Christophe
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorJOLY, Pierre
dc.date.accessioned2022-04-22T07:36:51Z
dc.date.available2022-04-22T07:36:51Z
dc.date.issued2022-03-05
dc.identifier.issn1179-1349 (Print) 1179-1349 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/139900
dc.description.abstractEnPURPOSE: In France, myocardial infarction (MI) was the second leading cause of years of life lost in 2019. Estimating the burden of MI in future years could help policymakers and other actors anticipate care and prevention needs and guide them in public health decision-making. MATERIALS AND METHODS: Using data from the French hospital discharge database from 2007 to 2015 (n = 519,400), demographic data, and an illness-death model, we projected incidence, prevalence, number of prevalent cases and mean age of incident MI cases in France. The methodology took into account the age-cohort effect on MI incidence, mortality of healthy and diseased subjects, and the time since disease onset. RESULTS: Projections highlighted an increase in MI prevalence in men between 2015 and 2035 from 2.52% (95% uncertainty interval (UI): [2.48-2.56]) in 2015 to 4.02% ([3.92-4.12]) in 2035, and from 0.85% ([0.83-0.87]) to 1.44% ([1.38-1.50]) in women. This corresponds to an increase of 365,000 cases between 2015 and 2035 (+81.1%) for men and 146,000 cases for women (+88.0%). The difference in the mean age of incident cases between men and women decreased from 9.52 in 2015 to 5.49 years in 2035. CONCLUSION: Our projections forecast an increase in MI prevalence between 2015 and 2035 in men and women, especially in relatively younger women. Using statistical models such as ours can help assess the impact of prevention campaigns for the main cardiovascular disease risk factors on the future MI prevalence.
dc.language.isoENen_US
dc.rightsAttribution-NonCommercial 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/us/*
dc.subject.enMyocardial infarction
dc.subject.enProjection
dc.subject.enBurden
dc.subject.enPrevalence
dc.subject.enIncidence
dc.subject.enAge-period-cohort model
dc.title.enEstimating the Future Burden of Myocardial Infarction in France Until 2035: An Illness-Death Model-Based Approach
dc.typeArticle de revueen_US
dc.identifier.doi10.2147/clep.S340031en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed35281209en_US
bordeaux.journalClinical Epidemiology / Clin Epidemiolen_US
bordeaux.page255-264en_US
bordeaux.volume14en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamBIOSTAT_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03648886
hal.version1
hal.date.transferred2022-04-22T07:36:53Z
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Clinical%20Epidemiology%20/%20Clin%20Epidemiol&rft.date=2022-03-05&rft.volume=14&rft.spage=255-264&rft.epage=255-264&rft.eissn=1179-1349%20(Print)%201179-1349%20(Linking)&rft.issn=1179-1349%20(Print)%201179-1349%20(Linking)&rft.au=KUHN,%20Johann&OLIE,%20Valerie&GRAVE,%20Clemence&LE%20STRAT,%20Yann&BONALDI,%20Christophe&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée